BRIEF-Cti Biopharma Reports Q4 Loss Per Share Of $0.20

Reuters · 03/17/2021 20:21
BRIEF-Cti Biopharma Reports Q4 Loss Per Share Of $0.20

- CTI Biopharma Corp CTIC.O:

  • CTI BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS

  • Q4 LOSS PER SHARE $0.20

  • EXPECT OUR CURRENT CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WILL ENABLE US TO FUND OUR OPERATIONS INTO Q2 OF 2021

Source text for Eikon: ID:nPn70JT7la

Further company coverage: CTIC.O


((Reuters.Briefs@thomsonreuters.com;))